Multiple Sclerosis Trial, By Invitation NCT06460077 Sponsor: Turku University Hospital Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, By Invitation

NCT06460077
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are willing and able to sign a consent form agreeing to take part in the study.
  • People who have been diagnosed with multiple sclerosis (MS) according to a specific set of diagnostic guidelines called the McDonald 2017 criteria.
  • People who have a series of brain MRI scans taken over time, covering at least one year.
  • People who are able to undergo two specific types of scans at the same time: a type of MRI called QSM and a type of nuclear medicine scan called TSPO-PET (confirm with trial site for details on what this involves).
  • People whose MRI scans show MS lesions that have iron rings or rims around them.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have another brain or nerve disease in addition to MS.
  • People who have another autoimmune disease in addition to MS.
  • People who have another serious or life-threatening disease affecting any other part of the body.
  • People who are pregnant or currently breastfeeding.
  • People who have taken corticosteroid medications (a type of anti-inflammatory drug) within four weeks before the scheduled scans.
  • People whose screening MRI shows significant abnormal findings that are not related to MS.
  • People who experience claustrophobia, or who have a history of moderate to severe anxiety disorder or panic attacks, which could make it difficult to complete the scans.
  • People for whom a PET scan is medically not appropriate for any reason.
  • People who have been exposed to experimental radiation in the past 12 months to a degree that would mean participating in this study exceeds safe radiation limits.
  • People who have previously had a bad reaction to a PET scan, including an allergic reaction to any substance used during a PET scan, or who have been unable to complete a PET scan in the past.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 24 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Turku University Hospital
Registry
ClinicalTrials.gov
Start date
3 October 2024
Est. completion
1 June 2028

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Number of lesions; Co-localization of lesions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov